VANCOUVER, Canada and HOUSTON, Texas, Aug.
31, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the
"Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company
focused on developing novel therapies for the treatment of prostate
cancer, today announced that David R.
Parkinson, President and Chief Executive Officer of ESSA
Pharma, will be presenting and hosting one-on-one meetings with
investors at two upcoming virtual investor conferences.
Peter Virsik, ESSA's Chief Operating
Officer, and David S. Wood, ESSA's
Chief Financial Officer, will also be available for one-on-one
Event: H.C. Wainwright Annual Global Investment
Date: Monday, September 13, 2021
Time (on-demand): 7:00 a.m. ET
Event: Oppenheimer Fall Healthcare Life Sciences &
Date: Tuesday, September 21, 2021
Time: 9:05 a.m. ET
Webcasts of the events can be accessed in the Investors/Events
& Presentations section of ESSA's website at
www.essapharma.com. Following the events, the webcasts will be
archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage
pharmaceutical company focused on developing novel and proprietary
therapies for the treatment of patients with prostate cancer. For
more information, please visit www.essapharma.com and follow
us on Twitter under @ESSAPharma.
SOURCE ESSA Pharma Inc